Editorials

The targeted-biotherapy revolution for vasculitis treatment: major advances but certain concerns persist

L. Guillevin¹

Referral Center for Rare Autoimmune and Systemic Diseases, French Vasculitis Study Group, Hôpital Cochin, University of Paris, France. loic.guillevin@orange.fr

CER16700
2023 Vol.41, N°4
PI 0780, PF 0783
Editorials

Free to view
(click on article PDF icon to read the article)

PMID: 36995330 [PubMed]

Received: 25/03/2023
Accepted : 27/03/2023
In Press: 30/03/2023
Published: 18/04/2023